Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV (mReach)
COPD, COPD Exacerbation
About this trial
This is an interventional diagnostic trial for COPD focused on measuring HIV, mobile health, spirometry
Eligibility Criteria
Inclusion Criteria:
- HIV infected
- Has an established longitudinal care provider in Baltimore, MD
- Confirmed COPD defined as post-bronchodilator FEV1/FVC<0.70
- Stable residence for duration of 6 month intervention
Exclusion Criteria:
- Age < 18 years
- Unable/unwilling to provide informed consent
- Failure to present to randomization visit
Sites / Locations
- Johns Hopkins ALIVE Clinic
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Usual care for COPD
mHealth Intervention
Usual care for AECOPD in the JHHCC consists of patient-initiated contact with the clinic for change in respiratory symptoms. Participants will be asked to complete a weekly symptom diary assessment which will be returned to the study staff at every 3-month visits. Participants contacting research staff with a worsening in respiratory symptoms will be referred to their assigned clinical providers.
For the mHealth intervention, investigators will use of the eResearch Technology, Inc system (ERT®; Philadelphia, PA) for home-based monitoring of spirometry and respiratory symptoms. In conjunction, wireless sensor-based inhalers will monitor the frequency of rescue inhaler use (Asthmapolis®; Madison, WI). As well, on a daily basis, participants in the early identification group will complete eight respiratory symptom questions from the COPD Assessment Test (CAT). Participants' short acting beta-agonist inhaler use will be monitored by an Asthmapolis Spiroscout Inhaler Tracker. Based on participant responses, flags or electronic notifications can be generated. Based on severity of symptoms and guidelines for recommended care, participants will be instructed to self-manage by optimizing inhaler use (if symptoms are mild) or present for an acute care visit at JHHCC if necessary.